You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《半日速報》恆指跌284點; 恆生科技指數跌97點 藥明生物升逾4% 藥明生物、農夫山泉、極兔速遞-W、藥明康德、領展房產基金創新高
恆指半日收25,383點,跌284點或1.1%。恆生科技指數報5,645點,跌97點或1.7%。國指跌116點或1.3%,報9,140點。 活躍重磅股表現: 美團(03690.HK) 收131元,下跌2.5%; 小米集團(01810.HK) 收57.1元,下跌2.3%; 港交所(00388.HK) 收438.4元,下跌2.2%; 阿里巴巴(09988.HK) 收117.7元,下跌2.2%; 騰訊(00700.HK) 收548元,下跌1.6%; 異動恆指及國指成份股: 藥明生物(02269.HK) 收31.25元,上升4.7%,創新高; 快手-W(01024.HK) 收72.9元,下跌4.3%; 農夫山泉(09633.HK) 收46.5元,上升3.6%,創新高; 極兔速遞-W(01519.HK) 收10.18元,上升3.5%,創新高; 藥明康德(02359.HK) 收98.5元,上升2.1%,創新高; 領展房產基金(00823.HK) 收43.85元,上升0.5%,創新高; ~
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account